Elite in HIV/AIDS

Dr. Karam Mounzer

Infectious Disease
Penn Medicine
Penn Infectious Diseases Penn Presbyterian
3801 Filbert Street, Medical Arts Building, Suite 103B, 
Philadelphia, PA 
On Staff At
Elite in HIV/AIDS
Penn Medicine
Penn Infectious Diseases Penn Presbyterian
3801 Filbert Street, Medical Arts Building, Suite 103B, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Karam Mounzer is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Mounzer is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, AIDS Dysmorphic Syndrome, AIDS Dementia Complex, and Myelitis.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 75 articles and participated in 3 clinical trials in the study of HIV/AIDS.

Graduate Institution
Saint Joseph's University Medical School
Residency
University of Medicine and Dentistry of New Jersey
Specialties
Infectious Disease
Licenses
Internal Medicine in PA
Board Certifications
Infectious Disease, 1997
Internal Medicine, 1995
Fellowships
University of Medicine and Dentistry of New Jersey
Languages Spoken
English
Gender
Male
Awards
Recognized annually in Philadelphia magazine's Top Docs issue from 2019 through 2025

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Provider Partners Health Plan
  • MEDICARE SNP
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Penn Infectious Diseases Penn Presbyterian
3801 Filbert Street, Medical Arts Building, Suite 103B, Philadelphia, PA 19104
Call: 215-662-9908

Additional Areas of Focus

Dr. Mounzer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Aspergillosis
Meningitis
Cellulitis
Encephalitis
Pulmonary Tuberculosis
Shingles
Osteomyelitis
Flu

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
A Phase 3b Multi-center, Open Label, Single Arm, 52-week Study, Evaluating the Feasibility, Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using a Fixed Dose Combination of Dolutegravir Plus Lamivudine (DOVATO) as a First Line Regimen
A Phase 3b Multi-center, Open Label, Single Arm, 52-week Study, Evaluating the Feasibility, Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using a Fixed Dose Combination of Dolutegravir Plus Lamivudine (DOVATO) as a First Line Regimen
Enrollment Status: Completed
Publish Date: October 21, 2021
Intervention Type: Drug
Study Phase: Phase 3
Pilot Study on Innate Activation and Viral Control in HIV-Infected Adults Undergoing an Analytical Treatment Interruption After Administration of Pegylated Interferon Alpha 2b With Broadly HIV-1 Neutralizing Antibodies (3BNC117, 10-1074)
Pilot Study on Innate Activation and Viral Control in HIV-Infected Adults Undergoing an Analytical Treatment Interruption After Administration of Pegylated Interferon Alpha 2b With Broadly HIV-1 Neutralizing Antibodies (3BNC117, 10-1074)
Enrollment Status: Unknown
Publish Date: June 25, 2021
Intervention Type: Drug
Study Drugs: Pegylated Interferon alpha 2b (peg-IFN-?2b), 3BNC117 + 10-1074
Study Phase: Phase 1
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Enrollment Status: Unknown
Publish Date: April 05, 2018
Intervention Type: Drug
Study Drug: Peg-IFN-?2b
Study Phase: Phase 2
View 4 Less Clinical Trials

99 Total Publications

Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline.
Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline.
Journal: Open forum infectious diseases
Published: June 25, 2025
View All 99 Publications
Similar Doctors
Elite in HIV/AIDS
Dr. Pablo Tebas
Infectious Disease
Elite in HIV/AIDS
Dr. Pablo Tebas
Infectious Disease

MacGregor Infection Medicine And Travel Program

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
 (0.8 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Pablo Tebas is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Tebas is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dysmorphic Syndrome. Dr. Tebas is currently accepting new patients.

Elite in HIV/AIDS
Dr. Ian D. Frank
Infectious Disease
Elite in HIV/AIDS
Dr. Ian D. Frank
Infectious Disease

University Of Penn - Medical Group

3400 Civic Ctr Blvd, 
Philadelphia, PA 
 (0.7 miles away)
215-662-6932
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ian Frank is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, Tissue Biopsy, and Myringotomy.

Distinguished in HIV/AIDS
Dr. William R. Short
Infectious Disease
Distinguished in HIV/AIDS
Dr. William R. Short
Infectious Disease

Penn Infectious Diseases Penn Presbyterian

3801 Filbert Street, Medical Arts Building, Suite 103B, 
Philadelphia, PA 
 (0.1 miles away)
215-662-9908
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Short is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Short is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome. Dr. Short is currently accepting new patients.

VIEW MORE HIV/AIDS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mounzer's expertise for a condition
ConditionClose
  • Elite
  • HIV/AIDS
    Dr. Mounzer is
    Elite
    . Learn about HIV/AIDS.
    See more HIV/AIDS experts
  • Distinguished
  • AIDS Dementia Complex
    Dr. Mounzer is
    Distinguished
    . Learn about AIDS Dementia Complex.
    See more AIDS Dementia Complex experts
  • AIDS Dysmorphic Syndrome
    Dr. Mounzer is
    Distinguished
    . Learn about AIDS Dysmorphic Syndrome.
    See more AIDS Dysmorphic Syndrome experts
  • Myelitis
    Dr. Mounzer is
    Distinguished
    . Learn about Myelitis.
    See more Myelitis experts
    • Experienced
    • Gonorrhea
      Dr. Mounzer is
      Experienced
      . Learn about Gonorrhea.
      See more Gonorrhea experts
    • Hepatitis
      Dr. Mounzer is
      Experienced
      . Learn about Hepatitis.
      See more Hepatitis experts
    • Hepatitis B
      Dr. Mounzer is
      Experienced
      . Learn about Hepatitis B.
      See more Hepatitis B experts
    • Hepatitis C
      Dr. Mounzer is
      Experienced
      . Learn about Hepatitis C.
      See more Hepatitis C experts
    • Hospital-Acquired Pneumonia
      Dr. Mounzer is
      Experienced
      . Learn about Hospital-Acquired Pneumonia.
      See more Hospital-Acquired Pneumonia experts
    • Sepsis
      Dr. Mounzer is
      Experienced
      . Learn about Sepsis.
      See more Sepsis experts
    View All 7 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.